In contrast to nontumorigenic MCF12A and non-invasive breast cancer cell line T47D, TET2 was predominantly localized in the cytoplasm in aggressive triple-negative breast cancer cell line MDA-MB-231, which is deficient in endogenous RARβ expression. The gene discussed is RARB; the disease is breast cancer.